ICU patient-on-a-chip emulating orchestration of mast cells and cerebral organoids in neuroinflammation
DOI: 10.1038/s42003-024-07313-z
Authors: Pelin Saglam-Metiner; Sena Yanasik; Yusuf Caglar Odabasi; Jennifer Modamio; Moritz Negwer; Cigir Biray-Avci; Ayse Guler; Ali Erturk; Ender Yildirim; Ozlem Yesil-Celiktas
Step 1: iPSC/ESC maintainance
day 0 ~ 1 (duration missing in database; assumed 1 day)
culture “adherent” human PSC in “mTeSR”. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table.
| concentration | unit | |
|---|---|---|
| dispase | 1 | g/l |
Step 2: mesoderm 1
day 1 ~ 5
culture “adherent” human PSC in “mTeSR” for “4” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “4” days.
| concentration | unit | |
|---|---|---|
| BMP4 | 8.0e-5 | g/l |
Ideally, “mesoderm” should be obtained at the end of culture.
Step 3: mesoderm 2
day 5 ~ 7
culture “adherent” human PSC in “StemPro” for “2” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| NEAA | 1 | % |
| Glutamine | 0.002 | mol/l |
| PSA | 0.5 | % |
| VEGF | 8.0e-5 | g/l |
| FGF | 2.5e-5 | g/l |
| SCF | 1.0e-4 | g/l |